Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2100609	恩格列净片	empagliflozin	Tablet	Chemical Drugs	License Renew	2021-08-16					view
JYHZ2100608	恩格列净片	empagliflozin	Tablet	Chemical Drugs	License Renew	2021-08-16					view
JYHZ2100607	恩格列净片	empagliflozin	Tablet	Chemical Drugs	License Renew	2021-08-16					view
JYHZ2100606	恩格列净片	empagliflozin	Tablet	Chemical Drugs	License Renew	2021-08-16					view
JYHZ2100605	恩格列净片	empagliflozin	Tablet	Chemical Drugs	License Renew	2021-08-16					view
JYHF2000084	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2020-09-03	上海勃林格殷格翰药业有限公司	Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd	Filed	2020-09-11	view
JYHF1700104	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2017-10-23	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2017-11-21	view
JYHF1700103	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2017-10-23	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Certificate Issued	2017-11-21	view
JYHB2300717	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2023-12-14		Boehringer Ingelheim International GmbH			view
JYHB2300716	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2023-12-14		Boehringer Ingelheim International GmbH			view
JYHB2300083	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2023-02-01		Boehringer Ingelheim International GmbH			view
JYHB2300082	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2023-02-01		Boehringer Ingelheim International GmbH			view
JYHB2200337	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2022-07-02		Boehringer Ingelheim International GmbH			view
JYHB2200336	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2022-07-02		Boehringer Ingelheim International GmbH			view
JYHB2200214	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2022-04-15					view
JYHB2200213	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2022-04-15					view
JYHB2200212	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2022-04-15					view
JYHB2200211	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2022-04-15					view
JYHB2200210	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2022-04-18					view
JYHB2000862	恩格列净片	empagliflozin	Tablet	Chemical Drugs	Supplementary Application	2020-06-16	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2020-06-22	view